INDUSTRIAL PRACTICES SUBCOMMITTEE 
OF THE FEDERAL INTERAGENCY 
ADVISORY COMMITTEE ON RECOMBINANT 
DNA RESEARCH 
Minutes of the Fourth Meeting* 
Tuesday, December 16, 1980 
1:00 to 3:00 p.m. 
Room 3104, New Executive Office Building 
Washington, D.C. 
Chairman's Introduction 
Dr. Omenn said that developments since the last subcommittee meeting, 
including the frenzied response on Wall Street on the first day of the Genentech 
public stock offering and the heavy press coverage of the Harvard University 
decision not to become a minority partner in a commercial venture to exploit 
\ 
recombinant DNA technology, show once again that this subcomittee is dealing 
with issues of great significance for science, industry, and society. 
Report from QSHA 
Dr. Adamson distributed copies of Dr. Bingham's September 24 letter 
to Dr. Fredrickson (Attachment B). As noted in the letter, Dr. Bingham 
estimates "that for completion of the NIOSH study and for implementation 
of OSHA's subsequent decisions, a period of approximately two years will 
be required." 
* A list of attendees is appended as Attachment A. 
[ 525 ] 
